TLCK is a trypsin-like serine protease inhibitor which can block lipopolysaccharide (LPS)- or cytokine-induced activation of nuclear factor iB (NF-iB), which, in turn blocks the induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (